← Back to Search

GAME-EOL for ICD User (GAME-EOL Trial)

N/A
Waitlist Available
Led By Jennifer Miller, PhD
Research Sponsored by Debra Moser
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, up to 3 months post intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a card game called the Hello Game can help people with heart devices (ICDs) and their families talk about end-of-life choices. The game asks thoughtful questions to encourage these important conversations. The goal is to see if playing the game helps families make better plans for end-of-life care. Card games have been used for a long time to facilitate conversations about end-of-life care, showing high satisfaction and effectiveness in discussing sensitive topics.

Eligible Conditions
  • Implantable Cardioverter Defibrillator (ICD) User
  • End-stage disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, up to 3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, up to 3 months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in attitudes about discussions and actions related to end of life
Change in concordance of end of life (EOL) Attitudes
Change in experience of end of life issues
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual care plus GAME-EOL interventionExperimental Treatment1 Intervention
Participant dyads in this group will receive usual care (standard clinical education materials) plus the GAME-EOL intervention.
Group II: Usual care recipientsActive Control1 Intervention
Participant dyads in this group will receive usual care (standard clinical education materials)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GAME-EOL
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Debra MoserLead Sponsor
2 Previous Clinical Trials
641 Total Patients Enrolled
Jennifer MillerLead Sponsor
1 Previous Clinical Trials
38 Total Patients Enrolled
University of Kentucky CCTSUNKNOWN
1 Previous Clinical Trials
7 Total Patients Enrolled
~12 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top